4//SEC Filing
Dhadha Ajay Kumar 4
Accession 0001213900-25-021172
CIK 0001415397other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:05 PM ET
Size
8.1 KB
Accession
0001213900-25-021172
Insider Transaction Report
Form 4
Dhadha Ajay Kumar
Director
Transactions
- Award
Common Stock
2025-03-05+350,000→ 351,667 total - Award
Warrant to purchase Common Stock
2025-03-05+250,000→ 250,000 totalExercise: $1.00Exp: 2026-12-31→ Common Stock (250,000 underlying)
Holdings
- 403,153(indirect: By Shanti Gems International Investments Ltd.)
Common Stock
Footnotes (1)
- [F1]350,000 shares of Common Stock and 250,000 Warrants to purchase shares of Common Stock of the issuer were received as compensation for the reporting person's service as a director and chairman of the Issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 5, 2025. The Warrants are exercisable immediately and will expire on December 31, 2026.
Documents
Issuer
Raphael Pharmaceutical Inc.
CIK 0001415397
Entity typeother
Related Parties
1- filerCIK 0002055843
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:05 PM ET
- Size
- 8.1 KB